Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesBlue Cross Blue Shield - North DakotaBCBS North Dakota Drug References Update | OpenPay…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - North DakotaPolicy I-173

    References

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - North Dakota Policy I-173 alerts

    Get alerted when Policy I-173 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document lists external reference materials used to support drug-related policy interpretation, including North Dakota Medicaid preferred drug list prior authorization criteria and the Radicava package insert. It does not establish independent coverage criteria or billing requirements.

    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyReferences
    Policy CodePolicy I-173
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionUse the listed external references when interpreting drug-related policy materials.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2External reference sources
    1PDL prior authorization criteria
    1Radicava package insert

    Reference Materials Overview

    This document provides external reference materials to support interpretation of drug-related policy information. It identifies the North Dakota Department of Human Services Medical Services Division’s Preferred Drug List (PDL) Prior Authorization Criteria and the Radicava (edaravone) package insert, revised November 2022. The document is reference-only and does not establish independent coverage criteria, authorization requirements, coding guidance, or billing requirements.

    External drug-policy reference materials
    Reference 1North Dakota Department of Human Services, Medical Services Division — Preferred Drug List (PDL) Prior Authorization Criteria. https://ndmedicaid.acentra.com/preferred-drug-list-pdl/#pdl
    Reference 2Mitsubishi Tanabe Pharma Corporation — Radicava (edaravone), for intravenous use [package insert]. Revised 11/2022.
    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyReferences
    Policy CodePolicy I-173
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionUse the listed external references when interpreting drug-related policy materials.
    SourceLink
    On This Page
    Reference Materials Overview

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.